National Health Investors, Inc. (FRA:WX6)
Germany · Delayed Price · Currency is EUR 65.50
+1.00 (1.55%)
Last updated: Jan 29, 2026, 6:00 PM CET
National Health Investors Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Rental Revenue | 267.1 | 257.05 | 249.23 | 217.7 | 271.05 | 307.21 |
Other Revenue | 65.62 | 55.29 | 49.72 | 36.37 | -1.55 | -3.13 |
| 357.57 | 335.58 | 320.39 | 278.76 | 297.17 | 329.69 | |
Revenue Growth (YoY | 8.40% | 4.74% | 14.93% | -6.19% | -9.86% | 3.65% |
Property Expenses | 17.26 | 11.17 | 11.51 | 9.79 | 11.64 | 9.65 |
Selling, General & Administrative | 27.75 | 21.79 | 19.82 | 25.32 | 19.34 | 14.56 |
Depreciation & Amortization | 77.97 | 71.44 | 69.97 | 70.88 | 80.8 | 83.15 |
Other Operating Expenses | 43.1 | 42.29 | 40.04 | 29.04 | 0.79 | 0.53 |
Total Operating Expenses | 166.08 | 146.69 | 141.34 | 135.03 | 112.56 | 107.89 |
Operating Income | 191.49 | 188.9 | 179.05 | 143.74 | 184.61 | 221.79 |
Interest Expense | -58.34 | -59.9 | -58.16 | -44.92 | -50.81 | -52.88 |
Other Non-Operating Income | -1.57 | - | 0.2 | 1.11 | 0.35 | - |
EBT Excluding Unusual Items | 131.57 | 129 | 121.09 | 99.93 | 134.15 | 168.91 |
Gain (Loss) on Sale of Investments | 6.26 | 6.26 | - | - | - | - |
Gain (Loss) on Sale of Assets | 5.3 | 6.68 | 14.72 | 28.34 | 32.5 | 21.32 |
Asset Writedown | - | -0.65 | -1.64 | -51.56 | -51.82 | - |
Other Unusual Items | 2.64 | -4.64 | 0.21 | -11.22 | -2.86 | -4.92 |
Pretax Income | 145.77 | 136.64 | 134.38 | 65.5 | 111.97 | 185.31 |
Earnings From Continuing Operations | 145.77 | 136.64 | 134.38 | 65.5 | 111.97 | 185.31 |
Minority Interest in Earnings | 1.49 | 1.35 | 1.27 | 0.9 | -0.16 | -0.19 |
Net Income | 147.26 | 137.99 | 135.65 | 66.4 | 111.8 | 185.13 |
Preferred Dividends & Other Adjustments | 0.18 | 0.12 | 0.06 | - | - | - |
Net Income to Common | 147.08 | 137.87 | 135.6 | 66.4 | 111.8 | 185.13 |
Net Income Growth | 16.14% | 1.72% | 104.29% | -40.61% | -39.61% | 15.38% |
Basic Shares Outstanding | 46 | 44 | 43 | 45 | 46 | 45 |
Diluted Shares Outstanding | 46 | 44 | 43 | 45 | 46 | 45 |
Shares Change (YoY) | 6.54% | 1.64% | -3.14% | -2.04% | 2.31% | 2.28% |
EPS (Basic) | 3.18 | 3.14 | 3.13 | 1.48 | 2.45 | 4.14 |
EPS (Diluted) | 3.17 | 3.13 | 3.13 | 1.48 | 2.44 | 4.14 |
EPS Growth | 8.88% | 0.15% | 111.16% | -39.34% | -41.06% | 12.81% |
Dividend Per Share | 3.620 | 3.600 | 3.600 | 3.600 | 3.803 | 4.410 |
Dividend Growth | 0.56% | - | - | -5.33% | -13.78% | 5.00% |
Operating Margin | 53.55% | 56.29% | 55.88% | 51.56% | 62.12% | 67.27% |
Profit Margin | 41.13% | 41.08% | 42.32% | 23.82% | 37.62% | 56.15% |
EBITDA | 269.46 | 260.34 | 249.02 | 214.62 | 265.41 | 304.94 |
EBITDA Margin | 75.36% | 77.58% | 77.72% | 76.99% | 89.31% | 92.50% |
D&A For Ebitda | 77.97 | 71.44 | 69.97 | 70.88 | 80.8 | 83.15 |
EBIT | 191.49 | 188.9 | 179.05 | 143.74 | 184.61 | 221.79 |
EBIT Margin | 53.55% | 56.29% | 55.88% | 51.56% | 62.12% | 67.27% |
Funds From Operations (FFO) | 216.41 | 200.65 | 190.37 | 158.96 | 211.08 | 246.18 |
FFO Per Share | 4.66 | 4.55 | 4.39 | 3.55 | 4.62 | 5.51 |
Adjusted Funds From Operations (AFFO) | - | 200.65 | 190.37 | 158.96 | 211.08 | 246.18 |
AFFO Per Share | - | 4.55 | 4.39 | 3.55 | 4.62 | 5.51 |
FFO Payout Ratio | 76.30% | 78.00% | 82.07% | 101.77% | 86.65% | 79.04% |
Revenue as Reported | 355.56 | 335.18 | 319.84 | 278.19 | 298.72 | 332.81 |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.